(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.
----------
AIM - WINNERS
----------
Genedrive PLC, up 27% at 45.75p, 12-month range 15.75p-47.84p. The molecular diagnostics firm has filed for approval to sell its Covid-19 test kit in the UK, as part of new Coronavirus Test Device Approvals regulations which came into effect last month. The company's kit is a rapid molecular diagnostic test that delivers positive results as quickly as 7.5 minutes and negative results at 17 minutes.
----------
Avacta Group PLC, up 23% at 129.70p, 12-month range 97.00p-291.80p. The biotechnology firm says its AffiDX Covid-19 antigen lateral flow test has received a CE mark for consumer self-test use in the UK and EU. The tests will be marketed by Medusa Healthcare under the brand name 'MeduFlow'. Medusa Healthcare is a subsidiary of Medusa 19 Ltd, a Manchester-based scientific equipment supplier.
----------
D4T4 Solutions PLC, up 13% at 322.00p, 12-month range 241.11p-410.00p. The data solutions provider says contract wins will contribute significant revenue in the current year. These include a multi-year contract extension and upsell to an unnamed US-based financial services company, and a license renewal and conversion to annual recurring revenue model by a bank based in Europe. Says contract wins add over GBP3 million per annum to annual recurring revenue as well as over GBP9 million to the current year's revenue.
----------
AIM - LOSERS
----------
Bluerock Diamonds PLC, down 16% at 25.14p, 12-month range 25.14p-67.00p. Shares hit 12-month low as diamond producer says operations at its Kareevlei mine in South Africa have been restricted. Says there has been 24 reported cases of Covid-19 amongst the Kareevlei workforce and 50% of the employees have not reported for work due to them having contact with affected employees. As such, operations at the site have been restricted until January 3. "The closure comes at a very unwelcome time as both lines are now operational, and management has been focusing on ramping up production," says Chair Mike Houston.
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.
Genedrive (GDR)
Avacta Group (AVCT)